Comparison of Intensive Treatment Regimens and Standard Treatment Regimen for Tuberculous Meningitis: Pharmacokinetics, Pharmacodynamics and Tolerability Study.

Trial Profile

Comparison of Intensive Treatment Regimens and Standard Treatment Regimen for Tuberculous Meningitis: Pharmacokinetics, Pharmacodynamics and Tolerability Study.

Completed
Phase of Trial: Phase II

Latest Information Update: 01 Jan 2013

At a glance

  • Drugs Moxifloxacin (Primary) ; Rifampicin (Primary) ; Rifampicin (Primary) ; Ethambutol
  • Indications Tubercular meningitis
  • Focus Pharmacokinetics
  • Most Recent Events

    • 06 Jun 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 03 Apr 2012 Interim results presented at the 22nd European Congress of Clinical Microbiology and Infectious Diseases.
    • 15 Dec 2011 Additional trial investigator identified as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top